Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulantJim Thom, Leesa Ivey, Grace Gilmore, et al.
Cannabis and Cannabinoid Research|August 9, 2021
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case ReportsJordan Guggisberg, Megan Schumacher, Grace Gilmore, et al.
Journal of Diabetes and Its Complications|February 6, 2019
Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapyDylan Zylla, Grace Gilmore, Justin Eklund, et al.
Cancers|December 11, 2022
Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic LeukemiaOmar Elaskalani, Grace Gilmore, Madison Hagger, et al.
Thrombosis Research|June 4, 2019
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfaEmmanuel J Favaloro, Grace Gilmore, Sandya Arunachalam, et al.
Seminars in Thrombosis and Hemostasis|September 20, 2017
Circulating MicroRNA as Thrombosis Sentinels: Caveats and ConsiderationsJasmine Tay, Jim Tiao, Quintin Hughes, et al.
Molecules (Basel, Switzerland)|October 20, 2017
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved PropertiesQuintin W Hughes, Bao T Le, Grace Gilmore, et al.
JCO Oncology Practice|January 9, 2026
Pilot Randomized Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Newly Diagnosed Advanced Pancreatic Cancer (CanPan)Dylan Zylla, Ella Chrenka, Kendall Lin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2020
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effectsEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Clinical Chemistry and Laboratory Medicine|March 4, 2020
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interferenceEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Pageof 2